99 related articles for article (PubMed ID: 11362608)
1. Phase III saquinavir clinical trials.
J Int Assoc Physicians AIDS Care; 1995 Jun; 1(5):33. PubMed ID: 11362608
[TBL] [Abstract][Full Text] [Related]
2. Saquinavir thwarts resistance.
AIDS Alert; 1995 Oct; 10(10):123. PubMed ID: 11362782
[TBL] [Abstract][Full Text] [Related]
3. Hoffmann-LaRoche announces international compassionate treatment program for saquinavir.
J Int Assoc Physicians AIDS Care; 1995 Jun; 1(5):32-4. PubMed ID: 11362607
[TBL] [Abstract][Full Text] [Related]
4. 3TC and saquinavir: we need them now.
Baker R
BETA; 1995 Sep; ():3. PubMed ID: 11362889
[TBL] [Abstract][Full Text] [Related]
5. Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group.
Collier AC; Coombs RW; Schoenfeld DA; Bassett RL; Timpone J; Baruch A; Jones M; Facey K; Whitacre C; McAuliffe VJ; Friedman HM; Merigan TC; Reichman RC; Hooper C; Corey L
N Engl J Med; 1996 Apr; 334(16):1011-7. PubMed ID: 8598838
[TBL] [Abstract][Full Text] [Related]
6. Combination therapy with zidovudine, didanosine and saquinavir.
Collier AC; Coombs RW; Schoenfeld DA; Bassett R; Baruch A; Corey L
Antiviral Res; 1996 Jan; 29(1):99. PubMed ID: 8721557
[TBL] [Abstract][Full Text] [Related]
7. FDA antiviral advisory hearings on lamivudine (Epivir, 3TC), saquinavir (Invirase), stavudine (Zerit, d4T), November 6-8. Food and Drug Administration.
AIDS Treat News; 1995 Oct; (no 233):4-5. PubMed ID: 11363038
[TBL] [Abstract][Full Text] [Related]
8. Clinical experience with saquinavir.
Vella S
AIDS; 1995 Dec; 9 Suppl 2():S21-S25. PubMed ID: 8775803
[TBL] [Abstract][Full Text] [Related]
9. A kinder, gentler ddC... for $7,200 a year.
GMHC Treat Issues; 1995 Dec; 9(12):2. PubMed ID: 11362996
[TBL] [Abstract][Full Text] [Related]
10. Potent new AIDS drugs underscore promise of combination therapy.
AIDS Alert; 1996 Jan; 11(1):1-4. PubMed ID: 11363225
[TBL] [Abstract][Full Text] [Related]
11. Resolution of refractory AIDS-related mucosal candidiasis after initiation of didanosine plus saquinavir.
Zingman BS
N Engl J Med; 1996 Jun; 334(25):1674-5. PubMed ID: 8628377
[No Abstract] [Full Text] [Related]
12. Drug-resistance patterns of saquinavir and other HIV proteinase inhibitors.
Roberts NA
AIDS; 1995 Dec; 9 Suppl 2():27-S32. PubMed ID: 8775804
[TBL] [Abstract][Full Text] [Related]
13. New saquinavir formulation enters clinical trials.
Torres G
GMHC Treat Issues; 1996 Jan; 10(1):7-8. PubMed ID: 11363375
[TBL] [Abstract][Full Text] [Related]
14. Boston, Galveston, Jackson County, Jefferson County, New York City, Portland--new saquinavir trial.
AIDS Treat News; 1995 Sep; (no 231):6. PubMed ID: 11362872
[TBL] [Abstract][Full Text] [Related]
15. [Roche begins phase III study with a new AIDS medication].
Immun Infekt; 1994 Jun; 22(3):VI. PubMed ID: 7927465
[No Abstract] [Full Text] [Related]
16. Saquinavir gets accelerated approval.
McGuire S
Posit Aware; 1996; 7(1):8. PubMed ID: 11363135
[TBL] [Abstract][Full Text] [Related]
17. Roche submits NDA for Invirase.
J Int Assoc Physicians AIDS Care; 1995 Sep; 1(8):37-8. PubMed ID: 11362796
[TBL] [Abstract][Full Text] [Related]
18. Saquinavir plus ddC reduces deaths by more than two-thirds.
J Int Assoc Physicians AIDS Care; 1996 Jun; 2(6):51. PubMed ID: 11363697
[TBL] [Abstract][Full Text] [Related]
19. Saquinavir: combination shows survival benefit; new formulation trial recruiting.
AIDS Treat News; 1996 May; (no 246):1-2. PubMed ID: 11363484
[TBL] [Abstract][Full Text] [Related]
20. Europe out of step with the US.
Alcorn K
J Int Assoc Physicians AIDS Care; 1996 Jan; 2(1):33-4. PubMed ID: 11363328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
